O
10.50
-0.08 (-0.76%)
| Penutupan Terdahulu | 10.58 |
| Buka | 10.67 |
| Jumlah Dagangan | 206,886 |
| Purata Dagangan (3B) | 289,848 |
| Modal Pasaran | 393,125,248 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Apr 2025 - 8 May 2025 |
| Hasil Dividen (DY TTM) | 15.36% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.25% |
| Nisbah Semasa (MRQ) | 28.89 |
| Aliran Tunai Operasi (OCF TTM) | -63.09 M |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Oruka Therapeutics, Inc. | Menurun | - |
AISkor Stockmoo
1.5
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.50 |
|
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 3.25% |
| % Dimiliki oleh Institusi | 85.78% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 45.00 (HC Wainwright & Co., 328.57%) | Beli |
| Median | 32.50 (209.52%) | |
| Rendah | 20.00 (Wolfe Research, 90.48%) | Beli |
| Purata | 32.50 (209.52%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 12.81 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 07 Feb 2025 | 45.00 (328.57%) | Beli | 11.40 |
| Wolfe Research | 04 Feb 2025 | 20.00 (90.48%) | Beli | 14.21 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 07 Mar 2025 | Pengumuman | Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting |
| 06 Mar 2025 | Pengumuman | Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update |
| 19 Feb 2025 | Pengumuman | Oruka Therapeutics to Present at Multiple March Investor Conferences |
| Hasil Dividen (DY TTM) | 15.36% |
| Purata Hasil Dividen 1T | 8.32% |
| Jangkaan Pembayaran Dividen Seterusnya | Aug 2025 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 29 Aug 2024 | - | 28 Aug 2024 | 1.613 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2024 | 1.61 | 1 | 8.32 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |